Krüger W, Müller G, Storch H, Kubel M, Richter V
Arch Geschwulstforsch. 1983;53(1):53-9.
The activity of adenosine deaminase was determined in lymphocytes, erythrocytes and blood plasma of 73 patients with different haematological malignancies and also in healthy control subjects. The enzyme activities were measured using adenosine as substrate and by analysis of released ammonia. Statistically significant decreased enzyme levels in lymphocytes and partial also in erythrocytes were observed in chronic lymphocytic leukaemia, Hodgkin's disease and multiple myeloma. The lower activities of ADA of these patients may be related to the impaired immunological function. In contrast in myeloid leukaemia, blast crisis of myeloid leukaemia and in acute leukaemias significant increased ADA levels in lymphocytes or blast cells were observed. Between the content of blast cells in peripheral blood and ADA activity of the mononuclear cell fraction exists a positive correlation. The increased ADA values of blast cells are a sign of an elevated purine metabolism.
在73例患有不同血液系统恶性肿瘤的患者以及健康对照者的淋巴细胞、红细胞和血浆中测定了腺苷脱氨酶的活性。以腺苷为底物并通过分析释放的氨来测量酶活性。在慢性淋巴细胞白血病、霍奇金病和多发性骨髓瘤中观察到淋巴细胞中的酶水平有统计学意义的下降,红细胞中也部分下降。这些患者较低的ADA活性可能与免疫功能受损有关。相比之下,在髓细胞白血病、髓细胞白血病的原始细胞危象和急性白血病中,观察到淋巴细胞或原始细胞中的ADA水平显著升高。外周血中原始细胞含量与单核细胞部分的ADA活性之间存在正相关。原始细胞中ADA值的升高是嘌呤代谢升高的一个标志。